| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/29/2008 | CA2324077C Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 07/29/2008 | CA2254914C Methods of terminal sterilization of biological products |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2214323C Compounds and compositions for delivering active agents |
| 07/24/2008 | WO2008089389A2 Treatment of cancers with acquired resistance to kit inhibitors |
| 07/24/2008 | WO2008089388A2 Treatment of cancers having resistance to chemotherapeutic agents |
| 07/24/2008 | WO2008089087A2 Tablet-in-tablet compositions |
| 07/24/2008 | WO2008088233A1 Therapeutical uses of eslicarbazepine |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087441A2 An influenza prevention and treatment composition |
| 07/24/2008 | WO2008087371A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | WO2008087198A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 07/24/2008 | WO2008070011A3 Combination of an hdac inhibitor and an antimetabolite |
| 07/24/2008 | WO2008068763A3 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles |
| 07/24/2008 | WO2008059949A9 Knockout animal exhibiting anxiety-like behavior |
| 07/24/2008 | WO2008059258A3 Imidazoles for treating multi-drug resistant bacterial infections |
| 07/24/2008 | WO2008057196A3 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
| 07/24/2008 | WO2008053352A3 Phenylpropionamide compounds and the use thereof |
| 07/24/2008 | WO2008051599A3 Combination therapies for treating alzheimer's disease using i. a. dimebon and dolepezil |
| 07/24/2008 | WO2008034087A3 Treating schizophrenia with combinations of levodopa and an antipsychotic agent |
| 07/24/2008 | WO2007146226A3 Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors |
| 07/24/2008 | WO2005099724A3 Functionalized water-soluble polyphosphazene and uses thereof as modifiers of biological agents |
| 07/24/2008 | US20080176964 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 07/24/2008 | US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain |
| 07/24/2008 | US20080176952 Management of Ophthalmologic Disorders, Including Macular Degeneration |
| 07/24/2008 | US20080176910 Methods for prevention and treatment of arteriosclerosis and restenosis |
| 07/24/2008 | US20080176909 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
| 07/24/2008 | US20080176823 androgen receptor modulator; analogs of androst-5-ene-3 beta ,17 beta -diol ("AED") or 1,3,5(10)-estratriene-17 alpha -ethynyl-3 beta ,17 beta -diol ("EED") |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176259 Uses of carbamoyl phosphate synthetase 1 (cps 1) and it's fragments for the diagnosis of liver diseases |
| 07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 07/24/2008 | US20080175917 Microparticles containing a H+,K+-ATP-ase inhibitor |
| 07/24/2008 | US20080175894 Methods of treating neurological conditions with hematopeitic growth factors |
| 07/24/2008 | US20080175848 Reducing matrix protein concentration via enzyme inhibitor and plasmin administration; prevention and treatment of fibrosis; wound healing agent |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175840 Methods for treating angiogenesis related disorders |
| 07/24/2008 | US20080175833 Using alpha -glucosidase administration to treat defects in glycogen synthesis or breakdown within muscles, liver and other cell types |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | CA2675980A1 Use of dast for treatment of cancers with acquired resistance to kit inhibitors |
| 07/24/2008 | CA2675979A1 Treatment of cancers having resistance to chemotherapeutic agents |
| 07/24/2008 | CA2675520A1 New combination for use in the treatment of inflammatory disorders |
| 07/23/2008 | EP1947192A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1946798A1 Compositions containing retinoid and chromenone derivatives |
| 07/23/2008 | EP1946788A2 Syringe for administering a therapeutic agent into tissue |
| 07/23/2008 | EP1946779A1 Combination of substituted pyrazolines and agent for treating dyslipidemia |
| 07/23/2008 | EP1946778A1 Active substance combination for the treatment of diabetes |
| 07/23/2008 | EP1946777A1 Substituted pyrazoline for preventing weight gain |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946755A1 Jelly composition |
| 07/23/2008 | EP1946753A1 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1945272A1 Method of scintigraphy |
| 07/23/2008 | EP1945265A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 07/23/2008 | EP1945242A2 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure |
| 07/23/2008 | EP1945224A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 07/23/2008 | EP1945221A1 Combination of roscovitine and a hdca inhibitor to treat prolifeative diseases |
| 07/23/2008 | EP1945212A1 Treatment of diabetes |
| 07/23/2008 | EP1945210A1 Use of a composition comprising an antacid, a mucolytic an a gelling agent in the treatment of cold |
| 07/23/2008 | EP1945185A2 Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| 07/23/2008 | EP1796725B1 Treatment or prevention of unscheluded bleeding in women on progestogen containing medication |
| 07/23/2008 | EP1587506B1 Administration of capsaicinoids |
| 07/23/2008 | EP1499289B1 Volume efficient controlled release dosage form |
| 07/23/2008 | EP1456401B1 Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 07/23/2008 | EP1453743B1 Pharmaceutical product and method with an adsorbent |
| 07/23/2008 | EP1420774B1 Preparation and diabetic use of gibberellins |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1239829B1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/23/2008 | EP1126830B1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 07/23/2008 | EP0957914B2 Formulation of 5-ht agonists |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | CN101228183A Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold |
| 07/23/2008 | CN101227927A Combination of HMG-CoA reductase inhibitors and mTOR inhibitors |
| 07/23/2008 | CN101227926A Method and composition for treating osteoarthritis |
| 07/23/2008 | CN101227908A Compositions for reducing the incidence of drug induced arrhythmia |
| 07/23/2008 | CN101227836A Lycopene formulations for the treatment of atherosclerotic conditions |
| 07/23/2008 | CN101224306A Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof |
| 07/23/2008 | CN101224193A Compound sustained release injection containing newborn blood vessel inhibitor and cytotoxic drugs |
| 07/23/2008 | CN100404533C New quinuclidine amide derivatives |
| 07/23/2008 | CN100404072C Extended, controlled-release pharmaceutical compositions using charged polymers |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/22/2008 | US7403805 Apparatus and method for noninvasive measurement of analytes from the conjunctiva using mid-infrared radiation |
| 07/22/2008 | US7402727 Model produced by injecting an immunodeficient mouse with a suspension of single cells of human small cell lung carcinoma SBC-5 cells to effect metastasis in the mouse's own bone; used for screening anticancer drugs |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family |
| 07/22/2008 | US7402604 4-oxy- or amino-substituted indole-2-carboxy acids, esters and amides, e.g., N-(2-hydroxy-1-phenylethyl) 4-hydroxy-1-methyl-1H-indole-2-carboxamide; nicotinic receptor agonist; conditions associated with reductions in nicotinic transmission; Alzheimer's disease, anxiety or schizophrenia |
| 07/22/2008 | US7402603 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 07/22/2008 | US7402591 Analgesic compositions containing buprenorphine |
| 07/22/2008 | US7402578 Methods for inhibiting cognitive deterioration in adults with down's syndrome |
| 07/22/2008 | US7402577 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 07/22/2008 | US7402575 Methods of treating inflammation |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402571 Methods and pharmaceutical compositions for healing wounds |